Appetite quiets down
Most patients notice cravings, snacking and food noise drop within days of starting.
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. It tells your brain you're full, slows stomach emptying, and stabilizes blood sugar. The medication amplifies this natural signal so the constant fight against hunger and cravings finally lets up.
Six-month trajectories from clinical data of the underlying molecules. GLP-1 produces continued, compounding loss; lifestyle changes alone tend to plateau and rebound.
Every body is different. These are the patterns we see most often across thousands of women on this protocol.
Most patients notice cravings, snacking and food noise drop within days of starting.
Body-weight reduction starts showing up on the scale and in how clothes fit.
Steady weekly loss with provider-guided dose titration. Mood and energy stabilize.
Average 15–20% body weight reduction in clinical data, with maintenance protocols built in.
Quick health questionnaire — about 5 minutes. We use it to match you to the right medication and dose.
A US-licensed clinician reviews your full profile and either prescribes or comes back with a question.
Your medication arrives free of charge with everything you need to start. Provider support is included.
Most patients notice reduced appetite within the first week. Visible weight loss typically begins within 4–6 weeks. Clinical studies show an average of 15–20% body weight loss over 6 months.
The most common side effects are mild nausea and digestive discomfort, which usually improve within the first few weeks. Your provider adjusts your dosage to minimize them.
Compounded medications are made by licensed compounding pharmacies under FDA oversight. Your prescription is reviewed by a licensed provider who evaluates your full medical history.